Table of Content


Chapter 1   Methodology and Scope
1.1    Market scope and definitions
1.2    Research design
1.2.1    Research approach
1.2.2    Data collection methods
1.3    Base estimates and calculations
1.3.1    Base year calculation
1.3.2    Key trends for market estimation
1.4    Forecast model
1.5    Primary research and validation
1.5.1    Primary sources
1.5.2    Data mining sources
Chapter 2   Executive Summary
2.1    Industry 360? synopsis
Chapter 3   Industry Insights
3.1    Industry ecosystem analysis
3.2    Industry impact forces
3.2.1    Growth drivers
3.2.1.1    Rise in clinical trials
3.2.1.2    Growing demand for adhering to stringent regulations
3.2.1.3    Increasing demand for long term data storage and preservation
3.2.1.4    Increasing investments in biobanking infrastructure
3.2.2    Industry pitfalls and challenges
3.2.2.1    Concerns related to data security and safety
3.2.2.2    Capital intensive nature of advanced storage facilities
3.3    Growth potential analysis
3.4    Gap analysis
3.5    Regulatory landscape
3.6    Technological landscape
3.7    Future market trends
3.8    Porter’s analysis
3.9    PESTEL analysis
Chapter 4   Competitive Landscape, 2024
4.1    Introduction
4.2    Company market share analysis
4.3    Competitive analysis of major market players
4.4    Competitive positioning matrix
4.5    Strategy outlook
Chapter 5   Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)
5.1    Key trends
5.2    Preclinical products
5.3    Clinical products
5.3.1    Human tissue
5.3.2    Organs
5.3.3    Stem cells
5.3.4    Other clinical products
Chapter 6   Market Estimates and Forecast, By Services, 2021 – 2034 ($ Mn)
6.1    Key trends
6.2    Biorepository services
6.2.1    Warehousing and storage
6.2.2    Sample processing
6.2.3    Transportation
6.2.4    Other services
6.3    Archiving solution services
6.3.1    Database indexing and management
6.3.2    Scanning and destruction
Chapter 7   Market Estimates and Forecast, By Phase, 2021 – 2034 ($ Mn)
7.1    Key trends
7.2    Preclinical
7.3    Phase I
7.4    Phase II
7.5    Phase III
7.6    Phase IV
Chapter 8   Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
8.1    Key trends
8.2    Pharmaceutical companies
8.3    Biotechnology companies
8.4    Contract research organizations
8.5    Academic and research institutions
Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1    Key trends
9.2    North America
9.2.1    U.S.
9.2.2    Canada
9.3    Europe
9.3.1    Germany
9.3.2    UK
9.3.3    France
9.3.4    Spain
9.3.5    Italy
9.4    Asia Pacific
9.4.1    China
9.4.2    Japan
9.4.3    India
9.4.4    Australia
9.4.5    South Korea
9.5    Latin America
9.5.1    Brazil
9.5.2    Mexico
9.5.3    Argentina
9.6    Middle East and Africa
9.6.1    South Africa
9.6.2    Saudi Arabia
9.6.3    UAE
Chapter 10   Company Profiles
10.1    American Type Culture Collection
10.2    Azenta US Inc.
10.3    BioStorage Technologies
10.4    Celerion
10.5    Celerion
10.6    Charles River Laboratories
10.7    CryoPort
10.8    Hamilton Company
10.9    IQVIA
10.10    Labcorp
10.11    NMDP BioTherapies
10.12    STC Biologics
10.13    Thermo Fisher Scientific
10.14    Veristat
10.15    VWR International (Avantor)